Status:
UNKNOWN
Shanghai Infants Gut Microbiome Associated Study
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Gastrointestinal Microbiome
Eligibility:
All Genders
1-28 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of probiotics on the gut microbiome of infants treated with antibiotics.
Detailed Description
This study aims to examin the impact of probiotics under 2 separate conditions, probiotics concurrent administration with antibiotic and probiotics administration during the recovery phase.Birth,7 day...
Eligibility Criteria
Inclusion
- Newborns with infectious diseases treated with antibiotic
Exclusion
- Gestational weeks \<37
- Birth weight \<2500g or ≥4000g
- History of asphyxia anoxia at birth
- With congenital metabolic diseases or hereditary diseases
- With gastrointestinal diseases
Key Trial Info
Start Date :
February 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03388112
Start Date
February 20 2017
End Date
December 31 2018
Last Update
January 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai 10th People's Hospital
Shanghai, Shanghai Municipality, China, 200072